The global Animal and Human Serum market size was valued at US$ million in 2024 and is forecast to a readjusted size of USD million by 2031 with a CAGR of %during review period.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from 拢2.6bn in 2015 to 拢4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China"s Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China"s pet medical market is about 楼67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 290%.
This report is a detailed and comprehensive analysis for global Animal and Human Serum market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Animal and Human Serum market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Animal and Human Serum market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Animal and Human Serum market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2020-2031
Global Animal and Human Serum market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2020-2025
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Animal and Human Serum
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Animal and Human Serum market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Grifols, Baxter, Animal Technologies, CSL, Octapharma, Biotest, Kedrion, Hualan Bio, CNBG, Shanghai RAAS, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
麻豆原创 Segmentation
Animal and Human Serum market is split by Type and by Application. For the period 2020-2031, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
麻豆原创 segment by Type
Human Serum Albumin (HSA)
Fetal Bovine Serum (FBS)
Other
麻豆原创 segment by Application
Hospitals and Clinics
Diagnostic Laboratories
Others
Major players covered
Grifols
Baxter
Animal Technologies
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Thermo Fisher
Merck
Cytiva
Biowest
Moregate BioTech
ExCell Bio
Internegocios
Tissue Culture Biologicals
Gemini
Corning
Biological Industries
VWR
Bovogen
R&D Systems
Seroxlab
麻豆原创 segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Animal and Human Serum product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Animal and Human Serum, with price, sales quantity, revenue, and global market share of Animal and Human Serum from 2020 to 2025.
Chapter 3, the Animal and Human Serum competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Animal and Human Serum breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2020 to 2031.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2020 to 2031.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2020 to 2025.and Animal and Human Serum market forecast, by regions, by Type, and by Application, with sales and revenue, from 2026 to 2031.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Animal and Human Serum.
Chapter 14 and 15, to describe Animal and Human Serum sales channel, distributors, customers, research findings and conclusion.
Please Note - This is an on demand report and will be delivered in 2 business days (48 Hours) post payment.
1 麻豆原创 Overview
1.1 Product Overview and Scope
1.2 麻豆原创 Estimation Caveats and Base Year
1.3 麻豆原创 Analysis by Type
1.3.1 Overview: Global Animal and Human Serum Consumption Value by Type: 2020 Versus 2024 Versus 2031
1.3.2 Human Serum Albumin (HSA)
1.3.3 Fetal Bovine Serum (FBS)
1.3.4 Other
1.4 麻豆原创 Analysis by Application
1.4.1 Overview: Global Animal and Human Serum Consumption Value by Application: 2020 Versus 2024 Versus 2031
1.4.2 Hospitals and Clinics
1.4.3 Diagnostic Laboratories
1.4.4 Others
1.5 Global Animal and Human Serum 麻豆原创 Size & Forecast
1.5.1 Global Animal and Human Serum Consumption Value (2020 & 2024 & 2031)
1.5.2 Global Animal and Human Serum Sales Quantity (2020-2031)
1.5.3 Global Animal and Human Serum Average Price (2020-2031)
2 Manufacturers Profiles
2.1 Grifols
2.1.1 Grifols Details
2.1.2 Grifols Major Business
2.1.3 Grifols Animal and Human Serum Product and Services
2.1.4 Grifols Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.1.5 Grifols Recent Developments/Updates
2.2 Baxter
2.2.1 Baxter Details
2.2.2 Baxter Major Business
2.2.3 Baxter Animal and Human Serum Product and Services
2.2.4 Baxter Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.2.5 Baxter Recent Developments/Updates
2.3 Animal Technologies
2.3.1 Animal Technologies Details
2.3.2 Animal Technologies Major Business
2.3.3 Animal Technologies Animal and Human Serum Product and Services
2.3.4 Animal Technologies Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.3.5 Animal Technologies Recent Developments/Updates
2.4 CSL
2.4.1 CSL Details
2.4.2 CSL Major Business
2.4.3 CSL Animal and Human Serum Product and Services
2.4.4 CSL Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.4.5 CSL Recent Developments/Updates
2.5 Octapharma
2.5.1 Octapharma Details
2.5.2 Octapharma Major Business
2.5.3 Octapharma Animal and Human Serum Product and Services
2.5.4 Octapharma Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.5.5 Octapharma Recent Developments/Updates
2.6 Biotest
2.6.1 Biotest Details
2.6.2 Biotest Major Business
2.6.3 Biotest Animal and Human Serum Product and Services
2.6.4 Biotest Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.6.5 Biotest Recent Developments/Updates
2.7 Kedrion
2.7.1 Kedrion Details
2.7.2 Kedrion Major Business
2.7.3 Kedrion Animal and Human Serum Product and Services
2.7.4 Kedrion Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.7.5 Kedrion Recent Developments/Updates
2.8 Hualan Bio
2.8.1 Hualan Bio Details
2.8.2 Hualan Bio Major Business
2.8.3 Hualan Bio Animal and Human Serum Product and Services
2.8.4 Hualan Bio Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.8.5 Hualan Bio Recent Developments/Updates
2.9 CNBG
2.9.1 CNBG Details
2.9.2 CNBG Major Business
2.9.3 CNBG Animal and Human Serum Product and Services
2.9.4 CNBG Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.9.5 CNBG Recent Developments/Updates
2.10 Shanghai RAAS
2.10.1 Shanghai RAAS Details
2.10.2 Shanghai RAAS Major Business
2.10.3 Shanghai RAAS Animal and Human Serum Product and Services
2.10.4 Shanghai RAAS Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.10.5 Shanghai RAAS Recent Developments/Updates
2.11 CBPO
2.11.1 CBPO Details
2.11.2 CBPO Major Business
2.11.3 CBPO Animal and Human Serum Product and Services
2.11.4 CBPO Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.11.5 CBPO Recent Developments/Updates
2.12 LFB Group
2.12.1 LFB Group Details
2.12.2 LFB Group Major Business
2.12.3 LFB Group Animal and Human Serum Product and Services
2.12.4 LFB Group Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.12.5 LFB Group Recent Developments/Updates
2.13 BPL
2.13.1 BPL Details
2.13.2 BPL Major Business
2.13.3 BPL Animal and Human Serum Product and Services
2.13.4 BPL Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.13.5 BPL Recent Developments/Updates
2.14 Sichuan Yuanda Shuyang
2.14.1 Sichuan Yuanda Shuyang Details
2.14.2 Sichuan Yuanda Shuyang Major Business
2.14.3 Sichuan Yuanda Shuyang Animal and Human Serum Product and Services
2.14.4 Sichuan Yuanda Shuyang Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.14.5 Sichuan Yuanda Shuyang Recent Developments/Updates
2.15 Thermo Fisher
2.15.1 Thermo Fisher Details
2.15.2 Thermo Fisher Major Business
2.15.3 Thermo Fisher Animal and Human Serum Product and Services
2.15.4 Thermo Fisher Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.15.5 Thermo Fisher Recent Developments/Updates
2.16 Merck
2.16.1 Merck Details
2.16.2 Merck Major Business
2.16.3 Merck Animal and Human Serum Product and Services
2.16.4 Merck Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.16.5 Merck Recent Developments/Updates
2.17 Cytiva
2.17.1 Cytiva Details
2.17.2 Cytiva Major Business
2.17.3 Cytiva Animal and Human Serum Product and Services
2.17.4 Cytiva Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.17.5 Cytiva Recent Developments/Updates
2.18 Biowest
2.18.1 Biowest Details
2.18.2 Biowest Major Business
2.18.3 Biowest Animal and Human Serum Product and Services
2.18.4 Biowest Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.18.5 Biowest Recent Developments/Updates
2.19 Moregate BioTech
2.19.1 Moregate BioTech Details
2.19.2 Moregate BioTech Major Business
2.19.3 Moregate BioTech Animal and Human Serum Product and Services
2.19.4 Moregate BioTech Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.19.5 Moregate BioTech Recent Developments/Updates
2.20 ExCell Bio
2.20.1 ExCell Bio Details
2.20.2 ExCell Bio Major Business
2.20.3 ExCell Bio Animal and Human Serum Product and Services
2.20.4 ExCell Bio Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.20.5 ExCell Bio Recent Developments/Updates
2.21 Internegocios
2.21.1 Internegocios Details
2.21.2 Internegocios Major Business
2.21.3 Internegocios Animal and Human Serum Product and Services
2.21.4 Internegocios Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.21.5 Internegocios Recent Developments/Updates
2.22 Tissue Culture Biologicals
2.22.1 Tissue Culture Biologicals Details
2.22.2 Tissue Culture Biologicals Major Business
2.22.3 Tissue Culture Biologicals Animal and Human Serum Product and Services
2.22.4 Tissue Culture Biologicals Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.22.5 Tissue Culture Biologicals Recent Developments/Updates
2.23 Gemini
2.23.1 Gemini Details
2.23.2 Gemini Major Business
2.23.3 Gemini Animal and Human Serum Product and Services
2.23.4 Gemini Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.23.5 Gemini Recent Developments/Updates
2.24 Corning
2.24.1 Corning Details
2.24.2 Corning Major Business
2.24.3 Corning Animal and Human Serum Product and Services
2.24.4 Corning Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.24.5 Corning Recent Developments/Updates
2.25 Biological Industries
2.25.1 Biological Industries Details
2.25.2 Biological Industries Major Business
2.25.3 Biological Industries Animal and Human Serum Product and Services
2.25.4 Biological Industries Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.25.5 Biological Industries Recent Developments/Updates
2.26 VWR
2.26.1 VWR Details
2.26.2 VWR Major Business
2.26.3 VWR Animal and Human Serum Product and Services
2.26.4 VWR Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.26.5 VWR Recent Developments/Updates
2.27 Bovogen
2.27.1 Bovogen Details
2.27.2 Bovogen Major Business
2.27.3 Bovogen Animal and Human Serum Product and Services
2.27.4 Bovogen Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.27.5 Bovogen Recent Developments/Updates
2.28 R&D Systems
2.28.1 R&D Systems Details
2.28.2 R&D Systems Major Business
2.28.3 R&D Systems Animal and Human Serum Product and Services
2.28.4 R&D Systems Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.28.5 R&D Systems Recent Developments/Updates
2.29 Seroxlab
2.29.1 Seroxlab Details
2.29.2 Seroxlab Major Business
2.29.3 Seroxlab Animal and Human Serum Product and Services
2.29.4 Seroxlab Animal and Human Serum Sales Quantity, Average Price, Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
2.29.5 Seroxlab Recent Developments/Updates
3 Competitive Environment: Animal and Human Serum by Manufacturer
3.1 Global Animal and Human Serum Sales Quantity by Manufacturer (2020-2025)
3.2 Global Animal and Human Serum Revenue by Manufacturer (2020-2025)
3.3 Global Animal and Human Serum Average Price by Manufacturer (2020-2025)
3.4 麻豆原创 Share Analysis (2024)
3.4.1 Producer Shipments of Animal and Human Serum by Manufacturer Revenue ($MM) and 麻豆原创 Share (%): 2024
3.4.2 Top 3 Animal and Human Serum Manufacturer 麻豆原创 Share in 2024
3.4.3 Top 6 Animal and Human Serum Manufacturer 麻豆原创 Share in 2024
3.5 Animal and Human Serum 麻豆原创: Overall Company Footprint Analysis
3.5.1 Animal and Human Serum 麻豆原创: Region Footprint
3.5.2 Animal and Human Serum 麻豆原创: Company Product Type Footprint
3.5.3 Animal and Human Serum 麻豆原创: Company Product Application Footprint
3.6 New 麻豆原创 Entrants and Barriers to 麻豆原创 Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Animal and Human Serum 麻豆原创 Size by Region
4.1.1 Global Animal and Human Serum Sales Quantity by Region (2020-2031)
4.1.2 Global Animal and Human Serum Consumption Value by Region (2020-2031)
4.1.3 Global Animal and Human Serum Average Price by Region (2020-2031)
4.2 North America Animal and Human Serum Consumption Value (2020-2031)
4.3 Europe Animal and Human Serum Consumption Value (2020-2031)
4.4 Asia-Pacific Animal and Human Serum Consumption Value (2020-2031)
4.5 South America Animal and Human Serum Consumption Value (2020-2031)
4.6 Middle East & Africa Animal and Human Serum Consumption Value (2020-2031)
5 麻豆原创 Segment by Type
5.1 Global Animal and Human Serum Sales Quantity by Type (2020-2031)
5.2 Global Animal and Human Serum Consumption Value by Type (2020-2031)
5.3 Global Animal and Human Serum Average Price by Type (2020-2031)
6 麻豆原创 Segment by Application
6.1 Global Animal and Human Serum Sales Quantity by Application (2020-2031)
6.2 Global Animal and Human Serum Consumption Value by Application (2020-2031)
6.3 Global Animal and Human Serum Average Price by Application (2020-2031)
7 North America
7.1 North America Animal and Human Serum Sales Quantity by Type (2020-2031)
7.2 North America Animal and Human Serum Sales Quantity by Application (2020-2031)
7.3 North America Animal and Human Serum 麻豆原创 Size by Country
7.3.1 North America Animal and Human Serum Sales Quantity by Country (2020-2031)
7.3.2 North America Animal and Human Serum Consumption Value by Country (2020-2031)
7.3.3 United States 麻豆原创 Size and Forecast (2020-2031)
7.3.4 Canada 麻豆原创 Size and Forecast (2020-2031)
7.3.5 Mexico 麻豆原创 Size and Forecast (2020-2031)
8 Europe
8.1 Europe Animal and Human Serum Sales Quantity by Type (2020-2031)
8.2 Europe Animal and Human Serum Sales Quantity by Application (2020-2031)
8.3 Europe Animal and Human Serum 麻豆原创 Size by Country
8.3.1 Europe Animal and Human Serum Sales Quantity by Country (2020-2031)
8.3.2 Europe Animal and Human Serum Consumption Value by Country (2020-2031)
8.3.3 Germany 麻豆原创 Size and Forecast (2020-2031)
8.3.4 France 麻豆原创 Size and Forecast (2020-2031)
8.3.5 United Kingdom 麻豆原创 Size and Forecast (2020-2031)
8.3.6 Russia 麻豆原创 Size and Forecast (2020-2031)
8.3.7 Italy 麻豆原创 Size and Forecast (2020-2031)
9 Asia-Pacific
9.1 Asia-Pacific Animal and Human Serum Sales Quantity by Type (2020-2031)
9.2 Asia-Pacific Animal and Human Serum Sales Quantity by Application (2020-2031)
9.3 Asia-Pacific Animal and Human Serum 麻豆原创 Size by Region
9.3.1 Asia-Pacific Animal and Human Serum Sales Quantity by Region (2020-2031)
9.3.2 Asia-Pacific Animal and Human Serum Consumption Value by Region (2020-2031)
9.3.3 China 麻豆原创 Size and Forecast (2020-2031)
9.3.4 Japan 麻豆原创 Size and Forecast (2020-2031)
9.3.5 South Korea 麻豆原创 Size and Forecast (2020-2031)
9.3.6 India 麻豆原创 Size and Forecast (2020-2031)
9.3.7 Southeast Asia 麻豆原创 Size and Forecast (2020-2031)
9.3.8 Australia 麻豆原创 Size and Forecast (2020-2031)
10 South America
10.1 South America Animal and Human Serum Sales Quantity by Type (2020-2031)
10.2 South America Animal and Human Serum Sales Quantity by Application (2020-2031)
10.3 South America Animal and Human Serum 麻豆原创 Size by Country
10.3.1 South America Animal and Human Serum Sales Quantity by Country (2020-2031)
10.3.2 South America Animal and Human Serum Consumption Value by Country (2020-2031)
10.3.3 Brazil 麻豆原创 Size and Forecast (2020-2031)
10.3.4 Argentina 麻豆原创 Size and Forecast (2020-2031)
11 Middle East & Africa
11.1 Middle East & Africa Animal and Human Serum Sales Quantity by Type (2020-2031)
11.2 Middle East & Africa Animal and Human Serum Sales Quantity by Application (2020-2031)
11.3 Middle East & Africa Animal and Human Serum 麻豆原创 Size by Country
11.3.1 Middle East & Africa Animal and Human Serum Sales Quantity by Country (2020-2031)
11.3.2 Middle East & Africa Animal and Human Serum Consumption Value by Country (2020-2031)
11.3.3 Turkey 麻豆原创 Size and Forecast (2020-2031)
11.3.4 Egypt 麻豆原创 Size and Forecast (2020-2031)
11.3.5 Saudi Arabia 麻豆原创 Size and Forecast (2020-2031)
11.3.6 South Africa 麻豆原创 Size and Forecast (2020-2031)
12 麻豆原创 Dynamics
12.1 Animal and Human Serum 麻豆原创 Drivers
12.2 Animal and Human Serum 麻豆原创 Restraints
12.3 Animal and Human Serum Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
13.1 Raw Material of Animal and Human Serum and Key Manufacturers
13.2 Manufacturing Costs Percentage of Animal and Human Serum
13.3 Animal and Human Serum Production Process
13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Animal and Human Serum Typical Distributors
14.3 Animal and Human Serum Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Grifols
Baxter
Animal Technologies
CSL
Octapharma
Biotest
Kedrion
Hualan Bio
CNBG
Shanghai RAAS
CBPO
LFB Group
BPL
Sichuan Yuanda Shuyang
Thermo Fisher
Merck
Cytiva
Biowest
Moregate BioTech
ExCell Bio
Internegocios
Tissue Culture Biologicals
Gemini
Corning
Biological Industries
VWR
Bovogen
R&D Systems
Seroxlab
听
听
*If Applicable.
